0001846253-23-000099.txt : 20230815 0001846253-23-000099.hdr.sgml : 20230815 20230815165653 ACCESSION NUMBER: 0001846253-23-000099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230814 FILED AS OF DATE: 20230815 DATE AS OF CHANGE: 20230815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOEHR MATTHEW W CENTRAL INDEX KEY: 0001237556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40720 FILM NUMBER: 231175587 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES RD #200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OmniAb, Inc. CENTRAL INDEX KEY: 0001846253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 600 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-250-7800 MAIL ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 600 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Avista Public Acquisition Corp. II DATE OF NAME CHANGE: 20210212 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2023-08-14 0 0001846253 OmniAb, Inc. OABI 0001237556 FOEHR MATTHEW W 5980 HORTON STREET, STE 600 EMERYVILLE CA 94608 1 1 0 0 President and CEO 0 Common Stock 2023-08-14 4 P 0 45000 5.48 A 2332919 D Restricted Stock Units Common Stock 10770 10770 D Restricted Stock Units Common Stock 33173 43943 D Restricted Stock Units Common Stock 53107 97050 D Restricted Stock Units Common Stock 79665 176715 D Restricted Stock Units Common Stock 109375 286090 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.370 to $5.590. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The Reporting Person previously reported certain awards of Restricted Stock Units (RSUs) in Table I of Form 4, but has elected to report the RSUs in Table II going forward. As a result, the total reported in Column 5 of Table I has been updated to subtract 286,090 RSUs outstanding on August 14, 2023. Represents RSUs previously reported in Table I. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting shall occur in full February 15, 2024. Represents RSUs previously reported in Table I. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting shall occur in full December 31, 2023. Represents RSUs previously reported in Table I. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting shall occur in two substantially equal annual installments beginning February 15, 2024. Represents RSUs previously reported in Table I. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting shall occur in three substantially equal annual installments, beginning December 7, 2023. Represents RSUs previously reported in Table I. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting shall occur in three substantially equal annual installments, beginning April 7, 2024. By: /s/ Charles S. Berkman For: Matthew W. Foehr 2023-08-15